NEOGENOMICS, INC. 
By
Ft. Myers, Florida - January 4, 2012 - NeoGenomics, Inc.
(NASD OTC BB: NGNM), a leading provider of cancer-focused
genetic testing services, announced today the
appointment of Dr. Barbara Chaitin as Director of Surgical
Pathology for NeoGenomics Laboratories and Medical Director
of the Fort Myers, Florida laboratory.
Dr. Chaitin was recently the Director of Esoteric Services,
and Chair of the Solid Tumor Committee, at AmeriPath, a
division of Quest Diagnostics Inc. Prior to that time, she
was National Medical Director and Head of Solid Tumor
Services at Genzyme Genetics in New York City. Dr. Chaitin's
professional experience also includes service as Associate
Medical Director at IMPATH Laboratories in New York City and
Bender Laboratory in Albany, New York. Early in her career,
she served as a Forensic Pathologist for New York State, and
as an Attending Pathologist and Assistant Professor of
Pathology at New York University Medical School and Albert
Einstein College of Medicine.
Dr. Chaitin attended Albert Einstein College of Medicine,
completed her Anatomic and Clinical Pathology Residency at
University of California in San Francisco, and completed
Fellowships in Surgical Pathology at Stanford University
Medical Center and at MD Anderson Cancer Center. She is Board
certified in both Forensic Pathology and Anatomic
Pathology.
Doug VanOort, NeoGenomics Chairman and CEO commented, "Dr.
Chaitin brings a wealth of experience and valuable expertise
to NeoGenomics. We have strong expertise in the application
of molecular genetics in oncology and hematology, and our
clients are requesting that we continue to enhance our
capabilities for solid tumor pathways and disease. We are
looking forward to Dr. Chaitin's medical leadership as we
expand our immunohistochemistry offering and introduce new
FISH and molecular tests targeted at solid tumor pathology.
We are excited to welcome Dr. Chaitin to our Medical Team and
to our company."
NeoGenomics, Inc. is a high-complexity CLIA-certified
clinical laboratory that specializes in cancer genetics
diagnostic testing, the fastest growing segment of the
laboratory industry.
1
The company's testing services include cytogenetics,
fluorescence in-situ hybridization (FISH), flow cytometry,
immunohistochemistry, anatomic pathology and molecular
genetic testing.
Headquartered in Fort Myers, FL, NeoGenomics has labs in
Nashville, TN, Irvine, CA, Tampa and Fort Myers, FL.
NeoGenomics services the needs of pathologists, oncologists,
other clinicians and hospitals throughout the United States.
For additional information about NeoGenomics, visit http://www.neogenomics.com.
(239) 325-2001 neogenomics@hawkassociates.com sjones@neogenomics.com
2
| distribué par | Ce noodl a été diffusé par NeoGenomics Inc. et initialement mise en ligne sur le site http://www.neogenomics.org. La version originale est disponible ici. Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-04 23:10:31 PM et restera accessible depuis ce lien permanent. Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité. |
| Documents associés | |
| NeoGenomics Appoints Dr. Barbara Chaitin as Director of Surgical Pathology and Medical Director for its Florida Lab |
